ACAT1 and neoplasm: Liu et al. [267] targeted ACAT-1 and incorporated photodynamic therapy (PDT) to engineer a tumor-penetrating nanovesicle system (namely EALP) for the co-delivery of avasimibe (AVA) and the photosensitizer phosphorbide A (PPa).